Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
复制标题
DOI:
10.1002/uog.12421
复制
发表时间:
2013-05-01
影响因子:
7.1
通讯作者:
Bujold, E.
中科院分区:
文献类型:
--
作者:
Roberge, S.;Nicolaides, K. H.;Bujold, E.
Objective To compare early vs late administration of low-dose aspirin on the risk of perinatal death and adverse perinatal outcome.Methods Databases were searched for keywords related to aspirin and pregnancy. Only randomized controlled trials that evaluated the prophylactic use of low-dose aspirin (50-150 mg/day) during pregnancy were included. The primary outcome combined fetal and neonatal death. Pooled relative risks (RR) with their 95% CIs were compared according to gestational age at initiation of low-dose aspirin ( 16 weeks of gestation).Results Out of 8377 citations, 42 studies (27 222 women) were included. Inclusion criteria were risk factors for pre-eclampsia, including: nulliparity, multiple pregnancy, chronic hypertension, cardiovascular or endocrine disease, prior gestational hypertension or fetal growth restriction, and/or abnormal uterine artery Doppler. When compared with controls, low-dose aspirin started at